Healthpoint Biotherapeutics

Smith & Nephew to Acquire Assets of Healthpoint Biotherapeutics

The acquired medical device firm specializes in products for acute, chronic and burn-related wound care.

Smith & Nephew, the global medical technology business, announced today that it has signed an agreement to acquire substantially all of the assets of Healthpoint Biotherapeutics for $782 million in cash. The transaction is subject to regulatory approval and is expected to close in December 2012.

No votes yet
Syndicate content